Day One

Wednesday, November 11 2020

Day Two

Thursday, November 12 2020

8:00 am Registration & Welcome Coffee

8:30 am Chair’s Opening Remarks

8:45 am Successful Change Management Through Transparency

Synopsis

• Understanding your audience and aligning with department values
• Involvement of ‘customers’ and clear communication
• Implementation of new strategic initiatives takes time and may require reinforcement

9:05 am Panel Discussion on Overcoming Barriers in the Implementation of LAFM Programs in Pharma and Biotech

  • James Mauro Director – Global Lab Asset Management Program, Merck
  • Kelly Edge Krupa Lab Asset Service Manager, Integrated Laboratory Strategy & Operations , Bristol-Myers Squibb
  • Jessie Dow Lab Operations Lead, Pfizer
  • Annie Kang Associate Director of Research Operations, Cue BioPharma

Synopsis

  • Implementing a LAFM program; what are the biggest barriers – infrastructure, cost, or mindset change?
  • Building a business case that appeals to stakeholders, what are they looking for?
  • Getting end users’ buy in: how to make it easy for scientists to help not hinder your LAFM plans?

9:35 am Our New Normal: Asset Management in the Time of COVID-19

Synopsis

  • Industry Trends
  • Observations & Best Practices
  • Looking Ahead

10:05 am Live Q&A

  • James Mauro Director – Global Lab Asset Management Program, Merck
  • Kelly Edge Krupa Lab Asset Service Manager, Integrated Laboratory Strategy & Operations , Bristol-Myers Squibb
  • Annie Kang Associate Director of Research Operations, Cue BioPharma
  • Jessie Dow Lab Operations Lead, Pfizer
  • Bill VanDeWeghe President & Chief Executive Officer, BioSurplus Inc

Synopsis

Ask the Speakers Your Burning Questions

10:25 am Virtual Speed Networking

10:55 am Morning Refreshments

1:00 pm Networking Lunch

2:00 pm Harnessing the Power of Asset Utilization Data

Synopsis

  • Scaling asset utilization monitoring to non-PC devices
  • Lessons learned
  • Same data, multiple insights (utilization, health, energy management)
  • Customer case study (presented by customer)

2:30 pm Live Q&A

2:40 pm Round Table Discussions:

Synopsis

1. Lab Planning From a EHS Perspective:

  • Where to place PPE stations to minimize cross-contamination and ensure easy workflow
  • Planning for safe transportation and collection of Biohazardous and Chemical waste
  • Design considerations in installing safety showers and other in-lab EHS equipment

 

 2. Surplus Asset Management and Disposition in Pharma:

  • How do you Manage your Equipment Lifecycles?
  • When do you decide to dispose of equipment to optimize use-length and price of sell?
  • Where do you look for second-hand equipment?

 

 

3:00 pm Afternoon Refreshments

Ensuring Compliance in Quality Controlled Labs

3:30 pm Equipment Periodic Review: A Business Case Applied in a QC Lab

  • Adolfo Scherch Utilities and Technical Services Coordinator, Novartis

Synopsis

  • Improve performance of site equipment periodic review
  • Seek opportunities to reduce costs and comply with quality policies
  • Spread and level the workload for qualification activities
  • Use CMMS to control periodic review activities

3:50 pm GxP Equipment Validation

Synopsis

  • Ensuring compliance for diagnostics and clinical labs
  • Verify the confidence, integrity and traceability of data which are generated
  • Establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce a product that meets predetermined specifications and quality

4:10 pm Live Q&A

4:30 pm Closing Remarks

GO TO DAY TWO